Thrivent Financial for Lutherans
DCPH

Thrivent Financial for Lutherans’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,575
Closed -$1.09M – 2607
2024
Q1 		$1.09M Sell
69,575
-8,145
-10% -$125K ﹤0.01% 1863
2023
Q4 		$1.25M Sell
77,720
-8,931
-10% -$114K ﹤0.01% 1693
2023
Q3 		$1.1M Sell
86,651
-53,158
-38% -$733K ﹤0.01% 1677
2023
Q2 		$1.97M Sell
139,809
-6,869
-5% -$98.3K ﹤0.01% 1347
2023
Q1 		$2.27M Hold
146,678
– – 0.01% 1217
2022
Q4 		$2.4M Sell
146,678
-51,658
-26% -$840K 0.01% 1141
2022
Q3 		$3.67M Buy
+198,336
New +$3.11M 0.01% 907
2021
Q1 		– Sell
-13,280
Closed -$758K – 2571
2020
Q4 		$758K Buy
13,280
+3,778
+40% +$224K ﹤0.01% 1937
2020
Q3 		$487K Sell
9,502
-3,889
-29% -$191K ﹤0.01% 1984
2020
Q2 		$800K Buy
13,391
+3,778
+39% +$202K ﹤0.01% 1646
2020
Q1 		$396K Buy
+9,613
New +$534K ﹤0.01% 1845

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Thrivent Financial for Lutherans's DCPH Position: Q2 2024 in Review

Thrivent Financial for Lutherans sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 69,575 shares — an estimated $1.09M sold.

Thrivent Financial for Lutherans first reported a position in DCPH in Q1 2020 and held it in 11 quarters. The position peaked at $3.67M in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Thrivent Financial for Lutherans reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 69,575 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.09M.
  • Thrivent Financial for Lutherans first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Thrivent Financial for Lutherans's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.67M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2024, filed 13 Aug 2024.